Mutated EGFR-IN-1 is a research compound designed as an inhibitor of mutated epidermal growth factor receptor (EGFR). It is primarily used in laboratory studies to investigate EGFR mutations and their role in cellular signaling pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Mutated EGFR-IN-1?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1,4-benzenediamine
pharmaceutical intermediate
Eglumine
pharmaceutical raw material
Entecavir
pharmaceutical raw material
2-amino-1,9-dihydro-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylene cyclopentyl)-6H-purine-6-one
pharmaceutical raw material
Adefovir dipivoxil
pharmaceutical raw material
Osimertinib
pharmaceutical raw material
Osimertinib mesylate
pharmaceutical raw material
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine
pharmaceutical intermediate
1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine
HTNTZPBKKCORTP-UHFFFAOYSA-N
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)N)N(C)CCN(C)C)OC
Sourcing Mutated EGFR-IN-1?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.